SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001567619-22-021461
Filing Date
2022-12-09
Accepted
2022-12-09 16:11:27
Documents
1
Period of Report
2022-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4/A doc1.html 4/A  
1 FORM 4/A doc1.xml 4/A 5698
  Complete submission text file 0001567619-22-021461.txt   7121
Mailing Address C/O WAVE LIFE SCIENCES LTD. 733 CONCORD AVE. CAMBRIDGE MA 02138
Business Address
TAKANASHI KEN (Reporting) CIK: 0001657768 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39041 | Film No.: 221454906

Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Issuer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations